T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment

Ahmed T. Ahmed; Siamak Mahmoudian Dehkordi; Sudeepa Bhattacharyya; Matthias Arnold; Gregory Louie; Boadie W. Dunlop; Liewei Wang; Richard M. Weinshilboum; Ranga Krishnan; William V. Bobo; Mark A. Frye; Rima Kaddurah-Daouk

doi:https://doi.org/10.1016/j.biopsych.2019.03.449

doi.org/10.1016/j.biopsych.2019.03.449

T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment

Ahmed T. Ahmed

18

,

Siamak Mahmoudian Dehkordi

2

,

..., Rima Kaddurah-Daouk

54

Biological Psychiatry10.60

Volume: 85, Issue: 10, Pages: S177 - S178

Published: May 1, 2019

Abstract

Metabolic signatures that align with depression phenotypes could better characterize the neurobiology of major depressive disorder (MDD) and its heterogeneity. We aimed to identify metabolomic markers of MDD phenotypes and their change after...

Paper Fields

Paper Details

Title

T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment

DOI

doi.org/10.1016/j.biopsych.2019.03.449

Published Date

May 1, 2019

Journal

Biological Psychiatry

Volume

85

Issue

10

Pages

S177 - S178

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History